Peripheral arterial disease (PAD) is increasingly prevalent but remains underdiagnosed and undertreated. The clinical significance of PAD spans beyond the symptoms it causes—rather, it is due to its associated cardiovascular morbidity and mortality. With respect to symptomology, the clinical manifestations of PAD will vary based on severity and anatomic distribution disease. The following chapter will focus on recognizing aortoiliac disease and will present a framework by which aortoiliac disease can be managed.
KeywordsAortoiliac occlusive disease Peripheral arterial disease Claudication Critical limb ischemia Angioplasty Stent
- 1.Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382(9901):1329–40. https://doi.org/10.1016/S0140-6736(13)61249-0.CrossRefPubMedGoogle Scholar
- 10.Jaff MR, White CJ, Hiatt WR, Fowkes GR, Dormandy J, et al. An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: a supplement to the inter-society consensus for the management of peripheral arterial disease (TASC II): the TASC Steering Committee. Catheter Cardiovasc Interv. 2015;86(4):611–25. https://doi.org/10.1002/ccd.26122.CrossRefPubMedGoogle Scholar
- 11.Bosiers M, Deloose K, Callaert J, Maene L, Beelen R, Keirse K, et al. BRAVISSIMO: 12-month results from a large scale prospective trial. J Cardiovasc Surg. 2013;54(2):235–53.Google Scholar